Evidence map›Paper›PMID 20368287›Full record

ArticleMolecular & cellular proteomics : MCP2010

Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.

Fanny Pilot-Storck, Emilie Chopin, Jean-François Rual, Anais Baudot, Pavel Dobrokhotov, Marc Robinson-Rechavi, Christine Brun, Michael E Cusick, David E Hill, Laurent Schaeffer and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Interactomes of Glycogen Synthase Kinase-3 Isoforms.Journal of proteome research · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Fanny Pilot-StorckUMR5239 Laboratoire de Biologie Moléculaire de la Cellule, Ecole Normale Supérieure de Lyon, Lyon, France.
Emilie Chopin
Jean-François Rual
Anais Baudot
Pavel Dobrokhotov
Marc Robinson-Rechavi
Christine Brun
Michael E Cusick
David E Hill
Laurent Schaeffer
Marc Vidal
Evelyne Goillot
École Normale Supérieure de Lyon · FRHarvard University · USInserm · FRSpanish National Cancer Research Centre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) pathway plays pivotal roles in cell survival, growth, and proliferation downstream of growth factors. Its perturbations are associated with cancer progression, type 2 diabetes, and neurological disorders. To better understand the mechanisms of action and regulation of this pathway, we initiated a large scale yeast two-hybrid screen for 33 components of the PI3K-mTOR pathway. Identification of 67 new interactions was followed by validation by co-affinity purification and exhaustive literature curation of existing information. We provide a nearly complete, functionally annotated interactome of 802 interactions for the PI3K-mTOR pathway. Our screen revealed a predominant place for glycogen synthase kinase-3 (GSK3) A and B and the AMP-activated protein kinase. In particular, we identified the deformed epidermal autoregulatory factor-1 (DEAF1) transcription factor as an interactor and in vitro substrate of GSK3A and GSK3B. Moreover, GSK3 inhibitors increased DEAF1 transcriptional activity on the 5-HT1A serotonin receptor promoter. We propose that DEAF1 may represent a therapeutic target of lithium and other GSK3 inhibitors used in bipolar disease and depression.

Indexed as

AnimalsCell LineDNA-Binding ProteinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansIntracellular Signaling Peptides and ProteinsNuclear ProteinsPhosphatidylinositol 3-KinasesPromoter Regions, GeneticProtein Interaction MappingProtein Serine-Threonine KinasesProteomeReceptor, Serotonin, 5-HT1ARecombinant Fusion ProteinsSignal TransductionDEAF1 protein, humanDNA-Binding ProteinsGlycogen Synthase Kinase 3glycogen synthase kinase 3 alphaGlycogen Synthase Kinase 3 betaGSK3B protein, humanIntracellular Signaling Peptides and ProteinsMTOR protein, humanNuclear ProteinsPhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProteomeReceptor, Serotonin, 5-HT1ARecombinant Fusion ProteinsTOR Serine-Threonine KinasesTranscription Factors

Identifiers

PMID20368287
PMCPMC2938100
OpenAlexW2134866534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.